1
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
Condition(s): Hyperlipidemia Last Updated: June 14, 2011Completed
1983 Clinical Trials for: “Hungary”, Page 1 of 100
Hide Studies Not Seeking New Volunteers
2
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Condition(s): Atrial Fibrillation; Stroke Last Updated: July 10, 2012Completed
3
Study to Investigate the Efficacy of Symbicort® SMART.
Condition(s): Asthma Last Updated: November 26, 2012Completed
4
A Study of Zomacton in Children With Growth Hormone Deficiency
Condition(s): Growth Hormone Deficiency Last Updated: July 16, 2012Completed
5
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Condition(s): Cancer; Cataract; Low Bone Mineral Density; Osteopenia; Osteoporosis; Prostate Cancer Last Updated: May 14, 2013Recruiting
6
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
Condition(s): Non Small Cell Lung Cancer Last Updated: December 19, 2012Active, not recruiting
7
A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain
Condition(s): Parkinson's Disease With Severe Pain Last Updated: October 9, 2012Recruiting
8
A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Are Previously Treated With Another Medicine But Were Not Satisfied With That Treatment
Condition(s): Urinary Bladder, Overactive; Urinary Bladder Diseases; Urologic Diseases Last Updated: April 11, 2013Active, not recruiting
9
Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition(s): NSCLC Last Updated: April 22, 2009Completed
10
Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
Condition(s): Parkinson Disease Last Updated: May 18, 2012Completed
11
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition(s): Venous Thrombosis Last Updated: August 16, 2012Active, not recruiting
12
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Condition(s): or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.; ErbB2 (HER2) Amplified Gastric; Neoplasms, Gastrointestinal Tract; Esophageal Last Updated: February 7, 2013Active, not recruiting
13
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
Condition(s): Advanced Breast Cancer; Breast Cancer Last Updated: January 29, 2013Active, not recruiting
14
Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
Condition(s): Cancer; Carcinoma; Castrate-Resistant Prostate Cancer; Prostate Cancer; Tumors Last Updated: August 8, 2012Completed
15
Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee
Condition(s): Pain Last Updated: May 28, 2012Terminated
16
4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease
Condition(s): Mild to Moderate Alzheimer's Disease Last Updated: August 10, 2010Completed
17
Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis
Condition(s): Relapsing Remitting Multiple Sclerosis Last Updated: August 16, 2012Active, not recruiting
18
A Study in Patients With Diabetic Kidney Disease
Condition(s): Diabetic Kidney Disease; Diabetic Nephropathy; Diabetic Glomerulosclerosis Last Updated: May 14, 2013Recruiting
19
IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
Condition(s): Metastatic Renal Cell Carcinoma Last Updated: February 8, 2013Active, not recruiting
20
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition(s): Cardiovascular Diseases Last Updated: June 4, 2012Completed
